KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Vertex Pharmaceuticals (VRTX) Net Income - Minority: 2011-2017

Historic Net Income - Minority for Vertex Pharmaceuticals (VRTX) over the last 6 years, with Dec 2017 value amounting to -$13.7 million.

  • Vertex Pharmaceuticals' Net Income - Minority fell 133.13% to -$28.4 million in Q3 2018 from the same period last year, while for Sep 2018 it was -$28.4 million, marking a year-over-year decrease of 133.13%. This contributed to the annual value of -$13.7 million for FY2017, which is 92.44% up from last year.
  • Vertex Pharmaceuticals' Net Income - Minority amounted to -$13.7 million in FY2017, which was up 92.44% from -$181.6 million recorded in FY2016.
  • Vertex Pharmaceuticals' 5-year Net Income - Minority high stood at -$13.7 million for FY2017, and its period low was -$181.6 million during FY2016.
  • Moreover, its 3-year median value for Net Income - Minority was -$153.7 million (2015), whereas its average is -$116.3 million.
  • Per our database at Business Quant, Vertex Pharmaceuticals' Net Income - Minority crashed by 625.60% in 2015 and then skyrocketed by 92.44% in 2017.
  • Yearly analysis of 4 years shows Vertex Pharmaceuticals' Net Income - Minority stood at -$21.2 million in 2014, then plummeted by 625.60% to -$153.7 million in 2015, then decreased by 18.19% to -$181.6 million in 2016, then spiked by 92.44% to -$13.7 million in 2017.